Get An Even Better Deal On CNMD Than Director Farkas Did
April 07, 2016 at 11:21 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on April 1, Conmed Corp.'s Director, Charles Farkas, invested $14,209.58 into 338 shares of CNMD, for a cost per share of $42.04..